返回期刊详情
H
Human Vaccines & Immunotherapeutics
IF
论文数221
被引数
期刊论文 221
发表时间
Safety and immunogenicity of a COVID-19–Influenza Combination nanoparticle vaccine (CIC) containing SARS-CoV-2 recombinant spike and quadrivalent influenza hemagglutinin with Matrix-M® adjuvant: A phase 1/2 clinical trial含SARS-CoV-2重组刺突和四价流感血凝素的Matrix-M®佐剂COVID-19–流感组合纳米颗粒疫苗(CIC)的安全性与免疫原性:一项1/2期临床试验

